CD19-Targeting Therapies Show Remarkable Growth, Revolutionizing Cancer Treatment with High Response Rates – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Nov 8, 2023--The <a ...
DUBLIN--(BUSINESS WIRE)--Nov 8, 2023--The <a ...
ANN ARBOR, Mich.--(BUSINESS WIRE)--Nov 8, 2023--<a ...
NEW YORK--(BUSINESS WIRE)--Nov 8, 2023--<a ...
<p style="TEXT-ALIGN:CENTER">This first-ever clinical study of an FcRn inhibitor in RA showed nipocalimab reduced levels of circulating IgG antibodies, including ACPAs, indicating they may play a key role in driving RA disease activity<p ...
PHOENIX--(BUSINESS WIRE)--Nov 7, 2023--City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced the appointment of <a ...
More than 40% of American adults are considered obese, yet the medications many take are rarely tested in bigger bodies.That's because they are not required to be included in drug studies. And often, they're explicitly excluded.“Clinical trials and dosing instructions don’t always ensure ...